ABL has manufactured a broad range of viral vectors
using a diversity of cell lines
We are pioneers in the manufacturing of viral vectors. We have been producing MVA, Vaccina and Pox virus since the early 90s. Today, we offer a broad range of viral vectors using a diversity of cell lines such as CEF, HeLa, HEK293, A549, VERO cells.
Thanks to our expertise of over 25 years, we are the right partner to support your Vaccinia and MVA projects with a successful track record in delivering GMP clinical batches up to phase 3 through adherent and suspension cell culture.